Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

radioimmunotherapy

  • You have access
    Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes
    Stig Palm, Tom Bäck, Sture Lindegren, Ragnar Hultborn, Lars Jacobsson and Per Albertsson
    Journal of Nuclear Medicine April 1, 2018, 59 (4) 646-651; DOI: https://doi.org/10.2967/jnumed.117.201285
  • You have access
    Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer
    Sarah M. Cheal, Edward K. Fung, Mitesh Patel, Hong Xu, Hong-fen Guo, Pat B. Zanzonico, Sebastien Monette, K. Dane Wittrup, Nai-Kong V. Cheung and Steven M. Larson
    Journal of Nuclear Medicine November 1, 2017, 58 (11) 1735-1742; DOI: https://doi.org/10.2967/jnumed.117.193250
  • You have access
    Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with 211At-MX35-F(ab′)2: Influence of Absorbed Tumor Dose and Effect on Long-Term Survival
    Tom Bäck, Nicolas Chouin, Sture Lindegren, Helena Kahu, Holger Jensen, Per Albertsson and Stig Palm
    Journal of Nuclear Medicine April 1, 2017, 58 (4) 598-604; DOI: https://doi.org/10.2967/jnumed.116.178327
  • You have access
    Remodeling the Vascular Microenvironment of Glioblastoma with α-Particles
    Katja Behling, William F. Maguire, Valentina Di Gialleonardo, Lukas E.M. Heeb, Iman F. Hassan, Darren R. Veach, Kayvan R. Keshari, Philip H. Gutin, David A. Scheinberg and Michael R. McDevitt
    Journal of Nuclear Medicine November 1, 2016, 57 (11) 1771-1777; DOI: https://doi.org/10.2967/jnumed.116.173559
  • You have access
    Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model
    In Ho Song, Tae Sup Lee, Yong Serk Park, Jin Sook Lee, Byung Chul Lee, Byung Seok Moon, Gwang Il An, Hae Won Lee, Kwang Il Kim, Yong Jin Lee, Joo Hyun Kang and Sang Moo Lim
    Journal of Nuclear Medicine July 1, 2016, 57 (7) 1105-1111; DOI: https://doi.org/10.2967/jnumed.115.167155
  • You have access
    Biokinetic Modeling and Dosimetry for Optimizing Intraperitoneal Radioimmunotherapy of Ovarian Cancer Microtumors
    Stig Palm, Tom Bäck, Börje Haraldsson, Lars Jacobsson, Sture Lindegren and Per Albertsson
    Journal of Nuclear Medicine April 1, 2016, 57 (4) 594-600; DOI: https://doi.org/10.2967/jnumed.115.167825
  • You have access
    α-Imaging Confirmed Efficient Targeting of CD45-Positive Cells After 211At-Radioimmunotherapy for Hematopoietic Cell Transplantation
    Sofia H.L. Frost, Brian W. Miller, Tom A. Bäck, Erlinda B. Santos, Donald K. Hamlin, Sue E. Knoblaugh, Shani L. Frayo, Aimee L. Kenoyer, Rainer Storb, Oliver W. Press, D. Scott Wilbur, John M. Pagel and Brenda M. Sandmaier
    Journal of Nuclear Medicine November 1, 2015, 56 (11) 1766-1773; DOI: https://doi.org/10.2967/jnumed.115.162388
  • You have access
    Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer
    Vessela Vassileva, Vineeth Rajkumar, Mario Mazzantini, Mathew Robson, Adam Badar, Surinder Sharma, Erik Årstad, Daniel Hochhauser, Mark F. Lythgoe, Geoffrey M. Boxer and Rosmund Barbara Pedley
    Journal of Nuclear Medicine August 1, 2015, 56 (8) 1239-1245; DOI: https://doi.org/10.2967/jnumed.115.157362
  • You have access
    The Advantage of Antibody Cocktails for Targeted Alpha Therapy Depends on Specific Activity
    Jordan B. Pasternack, Jason D. Domogauer, Alisha Khullar, John M. Akudugu and Roger W. Howell
    Journal of Nuclear Medicine December 1, 2014, 55 (12) 2012-2019; DOI: https://doi.org/10.2967/jnumed.114.141580
  • You have access
    Dose Escalation and Dosimetry of First-in-Human α Radioimmunotherapy with 212Pb-TCMC-Trastuzumab
    Ruby Meredith, Julien Torgue, Sui Shen, Darrell R. Fisher, Eileen Banaga, Patty Bunch, Desiree Morgan, Jinda Fan and J. Michael Straughn
    Journal of Nuclear Medicine October 1, 2014, 55 (10) 1636-1642; DOI: https://doi.org/10.2967/jnumed.114.143842

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire